drugset / Trial / NCT06364267
Low Dose Exemestane vs Low Dose Tamoxifen in Post-menopausal Women at High Risk for Breast Cancer.
Phase 2
Recruiting
140 enrolled
Andrea DeCensi
Breast Cancer Research Foundation · collabDana-Farber/Brigham and Women's Cancer Center · collabHerbert Irving Comprehensive Cancer Center · collabIstituto Europeo di Oncologia · collab
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of the study is to to compare low dose of exemestane (babyexe) versus low dose of tamoxifen (babytam) in terms of change of quality of life from baseline to 12 months.
Timeline
- Start
- 2025-10-01
- Primary completion
- 2027-01-31
- Completion
- 2027-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Exemestane | Small molecule | 25 mg | — |
| Subject | Tamoxifen | Small molecule | 10 mg | — |